BioNxt Solutions Inc. (ETR:BXT)
0.3400
+0.0160 (4.94%)
At close: May 16, 2025, 5:30 PM CET
BioNxt Solutions Revenue
BioNxt Solutions had revenue of 17.10K CAD in the quarter ending September 30, 2024, with 198.55% growth. This brings the company's revenue in the last twelve months to 42.01K, down -89.20% year-over-year. In the year 2023, BioNxt Solutions had annual revenue of 372.25K with 25.15% growth.
Revenue (ttm)
42.01K CAD
Revenue Growth
-89.20%
P/S Ratio
1,430.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
39.89M EUR
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 77.82B |
Deutsche Telekom AG | 120.25B |
Allianz SE | 107.35B |
Rheinmetall AG | 10.48B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
Siemens Energy AG | 37.44B |
Siemens Healthineers AG | 23.14B |
BioNxt Solutions News
- 9 days ago - BioNxt Reports Expanded Research, Development and Commercialization Capability with Centralized Munich Laboratory - Wallstreet:Online
- 17 days ago - BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization - Wallstreet:Online
- 20 days ago - BioNxt Solutions Announces Delay In Filing 2024 Annual Financial Statements - Wallstreet:Online
- 4 weeks ago - BioNxt Solutions Prepares for Human Bioequivalence Study For MS - Wallstreet:Online